Blue Bell Pharmaceutical Firm Testing New Malaria Vaccine
Inovio Pharmaceuticals and PATH Malaria Vaccine Initiative will partner again to build on earlier research
The Blue Bell pharmaceutical firm Inovio Pharmaceuticals will test a new vaccine for malaria.
According to the Philadelphia Business Journal, Inovio will partner with PATH Malaria Vaccine Initiative to build on an earlier research partnership.
The new vaccine will combine genetically-engineered DNA with a vaccine delivery technology called electroporation, according to the article.
